Table 4.
Adverse events (AEs) with an incidence ≥5%
Abbreviations: Q2W, every 2 weeks; Q3W, every 3 weeks; XELOX, capecitabine plus oxaliplatin.
Adverse events (AEs) with an incidence ≥5%
Abbreviations: Q2W, every 2 weeks; Q3W, every 3 weeks; XELOX, capecitabine plus oxaliplatin.